Literature DB >> 17767135

Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients.

Laura C Collins1, Ninah A Achacoso, Larissa Nekhlyudov, Suzanne W Fletcher, Reina Haque, Charles P Quesenberry, Najeeb S Alshak, Balaram Puligandla, Gilbert L Brodsky, Stuart J Schnitt, Laurel A Habel.   

Abstract

Flat epithelial atypia is an alteration of mammary terminal duct lobular units that is considered to be a precursor to, or early stage in, the development of some forms of ductal carcinoma in situ. No prior study has systematically evaluated the relationship between various clinico-pathologic features of ductal carcinoma in situ and the presence of coexistent flat epithelial atypia. An understanding of such relationships could provide insight into the connection between flat epithelial atypia and ductal carcinoma in situ. We reviewed slides from 543 ductal carcinoma in situ patients enrolled in a case-control study assessing epidemiologic and pathologic risk factors for local recurrence. We examined the association between the presence of flat epithelial atypia and various clinical factors, pathologic features of the ductal carcinoma in situ, and the presence of coexistent atypical ductal hyperplasia, lobular neoplasia, and non-atypical columnar cell lesions. In univariate analysis, the presence of flat epithelial atypia was significantly related to ductal carcinoma in situ nuclear grade (most common in low grade, least common in high grade; P<0.0001), architectural pattern (most common in micropapillary and cribriform, least common in comedo; P<0.0001), absence of comedo necrosis (P<0.001), absence of stromal desmoplasia (P=0.02) and absence of stromal inflammation (P=0.03). In multivariable analysis, features of ductal carcinoma in situ independently associated with flat epithelial atypia were micropapillary and cribriform patterns and absence of comedo necrosis. Additionally, flat epithelial atypia was significantly associated with the presence of atypical ductal hyperplasia, lobular neoplasia, and columnar cell lesions in both univariate and multivariable analyses. These observations provide support for a precursor-product relationship between flat epithelial atypia and ductal carcinoma in situ lesions that exhibit particular features such as micropapillary and cribriform patterns and absence of comedo necrosis.

Entities:  

Mesh:

Year:  2007        PMID: 17767135     DOI: 10.1038/modpathol.3800949

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  10 in total

Review 1.  Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?

Authors:  Gulisa Turashvili; Malcolm Hayes; Blake Gilks; Peter Watson; Samuel Aparicio
Journal:  Virchows Arch       Date:  2008-04-24       Impact factor: 4.064

2.  Update 2010 of the German AGO Recommendations for the Diagnosis and Treatment of Early and Metastatic Breast Cancer - Chapter B: Prevention, Early Detection, Lifestyle, Premalignant Lesions, DCIS, Recurrent and Metastatic Breast Cancer.

Authors:  Christoph Thomssen; Nadia Harbeck
Journal:  Breast Care (Basel)       Date:  2010-10-27       Impact factor: 2.860

3.  Morphological parameters of flat epithelial atypia (FEA) in stereotactic vacuum-assisted needle core biopsies do not predict the presence of malignancy on subsequent surgical excision.

Authors:  Simonetta Bianchi; Benedetta Bendinelli; Isabella Castellano; Quirino Piubello; Giuseppe Renne; Maria Grazia Cattani; Domenica Di Stefano; Giovanna Carrillo; Licia Laurino; Alessandra Bersiga; Carmela Giardina; Stefania Dante; Carla Di Loreto; Carmela Quero; Concetta Maria Antonacci; Domenico Palli
Journal:  Virchows Arch       Date:  2012-09-01       Impact factor: 4.064

Review 4.  Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review.

Authors:  Kelly L Mooney; Lawrence W Bassett; Sophia K Apple
Journal:  Mod Pathol       Date:  2016-08-19       Impact factor: 7.842

5.  Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease.

Authors:  Ying Liu; Rulla M Tamimi; Catherine S Berkey; Walter C Willett; Laura C Collins; Stuart J Schnitt; James L Connolly; Graham A Colditz
Journal:  Pediatrics       Date:  2012-04-09       Impact factor: 7.124

Review 6.  Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures.

Authors:  Olga Golubnitschaja; Manuel Debald; Kristina Yeghiazaryan; Walther Kuhn; Martin Pešta; Vincenzo Costigliola; Godfrey Grech
Journal:  Tumour Biol       Date:  2016-07-22

Review 7.  Breast cancer risk accumulation starts early: prevention must also.

Authors:  Graham A Colditz; Kari Bohlke; Catherine S Berkey
Journal:  Breast Cancer Res Treat       Date:  2014-05-13       Impact factor: 4.872

Review 8.  Are Columnar Cell Lesions the Earliest Non-Obligate Precursor in the Low-Grade Breast Neoplasia Pathway?

Authors:  Sarah Strickland; Gulisa Turashvili
Journal:  Curr Oncol       Date:  2022-08-11       Impact factor: 3.109

9.  Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk.

Authors:  Ying Liu; Graham A Colditz; Bernard Rosner; Catherine S Berkey; Laura C Collins; Stuart J Schnitt; James L Connolly; Wendy Y Chen; Walter C Willett; Rulla M Tamimi
Journal:  J Natl Cancer Inst       Date:  2013-08-28       Impact factor: 13.506

10.  Persistent Increased Frequency of Genomic Instability in Women Diagnosed with Breast Cancer: Before, during, and after Treatments.

Authors:  Márcia Fernanda Correia Jardim Paz; André Luiz Pinho Sobral; Jaqueline Nascimento Picada; Ivana Grivicich; Antonio Luiz Gomes Júnior; Ana Maria Oliveira Ferreira da Mata; Marcus Vinícius Oliveira Barros de Alencar; Rodrigo Mendes de Carvalho; Kátia da Conceição Machado; Muhammad Torequl Islam; Ana Amélia de Carvalho Melo Cavalcante; Juliana da Silva
Journal:  Oxid Med Cell Longev       Date:  2018-06-14       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.